Question 1

What did the study find about the role of IGF1R and p95HER2 in predicting survival?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Retrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Non Small Cell Lung Cancer (NSCLC) clinical trial (NCT00763607). Contact the study team or your healthcare provider for specific answers.

Question 2

How might the results of this study affect my treatment plan?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Retrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Non Small Cell Lung Cancer (NSCLC) clinical trial (NCT00763607). Contact the study team or your healthcare provider for specific answers.

Question 3

Are there other tests or studies I should consider based on my situation?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Retrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Non Small Cell Lung Cancer (NSCLC) clinical trial (NCT00763607). Contact the study team or your healthcare provider for specific answers.

Question 4

What are the next steps if my tumor tissue shows high levels of these proteins?

Accepted Answer

This is a question you may want to discuss with your doctor regarding the Retrospective Study Evaluating IGF1R And p95HER2 as Prognostic Factors in Non Small Cell Lung Cancer (NSCLC) clinical trial (NCT00763607). Contact the study team or your healthcare provider for specific answers.

What this study is about